Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor R Grann

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Lancet. Oncology|July 11, 2002
Population screening for cancer-related germline gene mutationsVictor R Grann, Judith S Jacobson
JAMA|June 10, 2004
Waiting time in prostate cancerAlfred I Neugut, Victor R Grann
JAMA|October 13, 2011
Defining variations in survival of BRCA1 and BRCA2 mutation carriersVictor R Grann, Ramon E Parsons
Studies in Health Technology and Informatics|September 14, 2004
Facilitating cancer research using natural language processing of pathology reportsHua Xu, Kristin Anderson, Victor R Grann, et al.
Drugs & Aging|February 13, 2004
Management of colorectal cancer in elderly patients: focus on the cost of chemotherapyMatthew J Matasar, Vijaya Sundararajan, Victor R Grann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based studyVijaya Sundararajan, Dawn Hershman, Victor R Grann, et al.
Journal of Occupational and Environmental Medicine|January 12, 2008
Arsenic exposure and anemia in Bangladesh: a population-based studyJulia E Heck, Yu Chen, Victor R Grann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based studyJohn J Doyle, Alfred I Neugut, Judith S Jacobson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysisDawn Hershman, Vijaya Sundararajan, Judith S Jacobson, et al.
Cancer Detection and Prevention|April 20, 2006
Breast biopsy and race/ethnicity among women without breast cancerJudith S Jacobson, Victor R Grann, Dawn Hershman, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Lancet. Oncology|July 11, 2002
Population screening for cancer-related germline gene mutationsVictor R Grann, Judith S Jacobson
JAMA|June 10, 2004
Waiting time in prostate cancerAlfred I Neugut, Victor R Grann
JAMA|October 13, 2011
Defining variations in survival of BRCA1 and BRCA2 mutation carriersVictor R Grann, Ramon E Parsons
Studies in Health Technology and Informatics|September 14, 2004
Facilitating cancer research using natural language processing of pathology reportsHua Xu, Kristin Anderson, Victor R Grann, et al.
Drugs & Aging|February 13, 2004
Management of colorectal cancer in elderly patients: focus on the cost of chemotherapyMatthew J Matasar, Vijaya Sundararajan, Victor R Grann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based studyVijaya Sundararajan, Dawn Hershman, Victor R Grann, et al.
Journal of Occupational and Environmental Medicine|January 12, 2008
Arsenic exposure and anemia in Bangladesh: a population-based studyJulia E Heck, Yu Chen, Victor R Grann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based studyJohn J Doyle, Alfred I Neugut, Judith S Jacobson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysisDawn Hershman, Vijaya Sundararajan, Judith S Jacobson, et al.
Cancer Detection and Prevention|April 20, 2006
Breast biopsy and race/ethnicity among women without breast cancerJudith S Jacobson, Victor R Grann, Dawn Hershman, et al.
Pageof 6